89 related articles for article (PubMed ID: 8664923)
1. [T1G3 of the bladder: our experience].
Chisena S; Antonelli D; Bernasconi S; Zaroli A; Buizza C; Belloni M; Mandressi A
Arch Ital Urol Androl; 1996 Feb; 68(1):51-4. PubMed ID: 8664923
[TBL] [Abstract][Full Text] [Related]
2. [Role of BCG in T1G3 bladder transitional cell carcinoma (TCC): our experience].
Comeri GC; Belvisi P; Conti G; Cretarola E; Duvia R; Furgoni R; Gianneo E; Radice GP
Arch Ital Urol Androl; 1996 Feb; 68(1):55-9. PubMed ID: 8664924
[TBL] [Abstract][Full Text] [Related]
3. [T1G3 transitional bladder neoplasms: what to do?].
Marcelli G; Bottanelli A; Scattoni V; Baroni GP; Rovellini P; Sciaraffia G; Toia G
Arch Ital Urol Androl; 1996 Feb; 68(1):67-9. PubMed ID: 8664926
[TBL] [Abstract][Full Text] [Related]
4. [T1G3 bladder tumors].
Dormia G; Minervini MS; Malagola G; Bertana F; Luongo P; Mazza L; Gonnella G; Longo G; Castellani R
Arch Ital Urol Androl; 1996 Feb; 68(1):29-32. PubMed ID: 8664917
[TBL] [Abstract][Full Text] [Related]
5. [pT1G3 tumor of the bladder].
Vicini D; Bettaglio G; Dallera P; Ruggieri M; Mirando P; Franceschetti GP; Sali C; Picchio GL
Arch Ital Urol Androl; 1996 Feb; 68(1):61-5. PubMed ID: 8664925
[TBL] [Abstract][Full Text] [Related]
6. [pT1G3 bladder carcinoma: parameters of a correct therapy].
Ruoppolo M; Dell'Orto P; Fenice O; Seveso M; Ferri P; Zaatar C; Tagliaferri A; Cogni M; Bellorofonte G; Tombolini P
Arch Ital Urol Androl; 1996 Feb; 68(1):17-20. PubMed ID: 8664914
[TBL] [Abstract][Full Text] [Related]
7. [T1G3 transitional cell carcinoma of the bladder: our experience with 44 patients treated with intravesical BCG after TUR].
Hurle R; Graziotti P; Ranieri A; Losa A; Micheli E; Lembo A
Arch Ital Urol Androl; 1996 Feb; 68(1):13-6. PubMed ID: 8664913
[TBL] [Abstract][Full Text] [Related]
8. [Radical cystectomy for superficial tumors in the BCG era].
Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
[TBL] [Abstract][Full Text] [Related]
9. [pT1G3 bladder carcinoma: our experience].
Dell'Orto P; Trinchieri A; D'Addezio F; Bernardini P; Mangiarotti B; Del Nero A; Pisani E
Arch Ital Urol Androl; 1996 Feb; 68(1):9-11. PubMed ID: 8664927
[TBL] [Abstract][Full Text] [Related]
10. [Conservative treatment of high-risk (T1G3) transitional carcinoma].
Catanzaro F; Torelli F; Catanzaro M; Cappellano F; Pizzoccaro M; Baruffi M; Sironi D; Pozzoli GL
Arch Ital Urol Androl; 1996 Feb; 68(1):21-4. PubMed ID: 8664915
[TBL] [Abstract][Full Text] [Related]
11. [T1G3 bladder tumors: 5 years later].
Pegoraro C; Bondovalli C; Dall'Oglio B; Schiavon L; Luciano M; Parma A
Arch Ital Urol Androl; 1996 Feb; 68(1):35-8. PubMed ID: 8664919
[TBL] [Abstract][Full Text] [Related]
12. [Transitional carcinoma of the bladder at the T1G3 stage: personal experience].
Roggia A; Pozzi E; Malvestiti GM
Arch Ital Urol Androl; 1996 Feb; 68(1):25-8. PubMed ID: 8664916
[TBL] [Abstract][Full Text] [Related]
13. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic radical cystoprostatectomy: our experience in a consecutive series of 10 patients with a 3 years follow-up.
Simonato A; Gregori A; Lissiani A; Bozzola A; Galli S; Gaboardi F
Eur Urol; 2005 Jun; 47(6):785-90; discussion 790-2. PubMed ID: 15925074
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
[TBL] [Abstract][Full Text] [Related]
16. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].
Denzinger S; Burger M; Fritsche HM; Ganzer R; Blana A; Wieland WF; Otto W
Aktuelle Urol; 2008 Jan; 39(1):58-61; discussion 62-3. PubMed ID: 18228189
[TBL] [Abstract][Full Text] [Related]
17. [T1G3 bladder tumors: our experience].
Pagano S; Franzoso F; Pachera F; Ruggeri P; Sorboli G
Arch Ital Urol Androl; 1996 Feb; 68(1):39-45. PubMed ID: 8664920
[TBL] [Abstract][Full Text] [Related]
18. [Partial cystectomy versus TUR in T1G3 tumors].
Manca GP; Martina G; Piras P; D'Alpaos M; Scuzarella S; Andreassi F
Arch Ital Urol Androl; 1996 Feb; 68(1):33-4. PubMed ID: 8664918
[TBL] [Abstract][Full Text] [Related]
19. T1G3 bladder cancer--the case for TUR and BCG.
Miller K
Front Radiat Ther Oncol; 2002; 36():147-50. PubMed ID: 11842744
[No Abstract] [Full Text] [Related]
20. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
